Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Liver Neoplasms
Interventions
RADIATION

Radiation therapy

6 fractions of 8-9Gy

DEVICE

chemoembolization

Up to 4 sessions

Trial Locations (11)

Unknown

UH Antwerp, Antwerp

UH Leuven, Leuven

UH Lille, Lille

Erasmus MC, Rotterdam

AMC, Amsterdam

VU MC, Amsterdam

LUMC, Leiden

Maastro, Maastricht

UMC Maastricht, Maastricht

UMC St Radboud, Nijmegen

UMC Utrecht, Utrecht

Sponsors
All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

VU University of Amsterdam

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Maastro Clinic, The Netherlands

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

University Hospital, Antwerp

OTHER

collaborator

University Hospital, Lille

OTHER

lead

Erasmus Medical Center

OTHER